VACCINES USED APPLICATIONS

Brand Owner (click to sort) Address Description
DEPOVAX Immunovaccine Technologies Inc. Suite 303 1819 Granville Street Halifax, Nova Scotia B3J3R1 Canada Vaccines used for applications to human and animal biological processes;
DEPOVAX Immunovaccine Technologies Inc. Suite 303 1819 Granville Street Halifax, Nova Scotia B3J3R1 Canada Vaccines used for applications to human and animal biological processes;
DEPOVAX Immunovaccine Technologies Inc. Suite 303 1819 Granville Street Halifax, Nova Scotia B3J3R1 Canada Vaccines used for applications to human and animal biological processes;
IMMUNOVACCINE TECHNOLOGIES Immunovaccine Technologies Inc. Suite 303 1819 Granville Street Halifax, Nova Scotia B3J3R1 Canada Vaccines used for applications to human and animal biological processes;IMMUNO VACCINE TECHNOLOGIES;TECHNOLOGIES;
IMV IMMUNOVACCINE ImmunoVaccine Technologies, Inc. Suite 303 1819 Granville Street Halifax, Nova Scotia B3J3R1 Canada Vaccines used for applications to human biological processes;
IVT Immunovaccine Technologies Inc. Suite 303 1819 Granville Street Halifax, Nova Scotia B3J3R1 Canada Vaccines used for applications to human and animal biological processes;IMMUNO VACCINE TECHNOLOGIES;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides multivalent vaccines for the treatment of B-cell malignancies (e.g., lymphomas and leukemias). The present invention also provides methods for the production of custom vaccines, including multivalent vaccines for the treatment of immune cell tumors malignancies as well as methods of treating immune cell tumors using custom vaccines.